Table 3.
Impacts on sexual and reproductive health - 24-month follow-up.
| Dependent Variable: |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Components of Sexual and Reproductive Health Index |
|||||||||||||
| Sexual and Reproductive Health Index |
Never Married |
Never Had Sex |
Never Pregnant - Extensive Margin |
Number of Partners in Past 12 Months - Extensive Margin |
Safe Sex Index - Standardized - Extensive Margin |
||||||||
| (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | (11) | (12) | ||
| GE | #### | 0.244*** | 0.024 | 0.028* | 0.030 | 0.036 | 0.011 | 0.019 | −0.412* | −0.458** | 0.215** | 0.198** | |
| (0.082) | (0.078) | (0.015) | (0.015) | (0.038) | (0.034) | (0.024) | (0.022) | (0.231) | (0.225) | (0.089) | (0.084) | ||
| GE+ (GE + cash) | #### | 0.372*** | 0.038** | 0.041*** | 0.062 | 0.072** | 0.018 | 0.026 | −0.651*** | ##### | 0.311*** | 0.311*** | |
| (0.087) | (0.084) | (0.014) | (0.014) | (0.040) | (0.035) | (0.027) | (0.026) | (0.203) | (0.203) | (0.113) | (0.111) | ||
| Any Treatment (GE or GE+) | #### | 0.309*** | 0.032** | 0.036** | 0.046 | 0.055* | 0.013 | 0.022 | −0.528*** | ##### | 0.262*** | 0.255*** | |
| (0.077) | (0.074) | (0.013) | (0.014) | (0.035) | (0.032) | (0.022) | (0.021) | (0.194) | (0.193) | (0.087) | (0.085) | ||
| Mean and Standard Deviation of un standardized dependent variable in the control group | 0.000 | 0.922 | 0.507 | 0.833 | 1.364 | 0.000 | |||||||
| (1.000) | (0.269) | (0.501) | (0.374) | (3.490) | (1.000) | ||||||||
| F-test for Equality of Parameters (p-value) | GE = GE+ | 0.085 | 0.075 | 0.275 | 0.281 | 0.361 | 0.218 | 0.803 | 0.778 | 0.242 | 0.198 | 0.356 | 0.266 |
| Lagged Dependent Variable/Age | No | Yes | No | Yes | No | Yes | No | Yes | No | Yes | No | Yes | |
| Number of observations | 1,174 | 1,174 | 1,174 | 1,174 | 1,174 | 1,174 | 1,174 | 1,174 | 1,174 | 1,174 | 1,174 | 1,174 | |
Notes: 0.01 - ***; 0.05 - **; 0.1 - *; OLS regressions at the individual level at the 24-month follow-up with standard errors (SEs) in parentheses clustered at the village level. All regressions include stratum fixed effects. Both the sexual and reproductive health index and the safe sex index have been constructed such that higher values imply better outcomes. Please refer to the pre-analysis plan in the appendix for index creation and the construction of index sub-components. 40 individuals from baseline were lost to the 24-month follow-up, leaving 1,176 individuals who were interviewed at endline. The sample is limited to only those observations with no item non-response for any of the index components or sub-components. Robustness of impact findings to how item non-response was handled is presented in Appendix A. Missing baseline covariates were replaced with the sample mean. If more than 10% of a baseline covariate was missing, an indicator variable for missing baseline covariate was also included in the regression and reported in the table. Questions on pregnancy, number of partners in the past 12 months and condom use were only asked to those who reported having ever had sex. The outcome indicators reported above are constructed on the extensive margin - with respondents who reported having never had sex assumed to be never pregnant, having no sexual partners, and assigned the highest score in the safe sex index. The number of partners in the past 12 months questions was administered using the random response method, in which the respondent rolls a die and adds the die roll to the answer and reports the sum to the enumerator. This conceals the true answer from the enumerator who cannot see the roll of the die.